$Verastem(VSTM)$ bullish 

Verastem, Inc. (VSTM) - Stock Analysis

Business and Industry: Verastem, Inc. operates in the biotechnology industry, focusing on the development and commercialization of small molecule drugs for the treatment of cancer. The biotechnology industry is experiencing significant advancements and growth potential in the field of cancer research and treatment.

Latest Earnings and Forecast:

2024 Q3 Earnings: In the third quarter of 2024, Verastem reported an EPS (Earnings Per Share) of -0.60 USD. The return on investment was -119.05%, indicating a negative profitability. The current financial ratios, such as gross profit margin, inventory turnover, and net profit margin are not available for this period.

Earnings Forecast: The earnings forecast for Verastem indicates a negative trend. For the fiscal years 2024, 2025, and 2026, the estimated EPS are -2.94 USD, -2.53 USD, and -1.74 USD, respectively. The forecasted gross income for these years are 8.95M USD, 15.07M USD, and 63.19M USD. The forecasting EBIT (Earnings Before Interest and Taxes) for the respective years are -118.70M USD, -133.65M USD, and -116.80M USD. These forecasts suggest challenging financial conditions, but it's important to closely monitor future earnings reports for any potential improvements.

Analyst Recommendations and Target Price:

Analyst Recommendation: Among the analysts, 2 recommend holding the stock, while 6 recommend buying it. It's important to consider multiple perspectives and conduct thorough research before making an investment decision.

Target Price: As per analyst forecasts, the mean target price for Verastem is 10.85714 USD, with a low target estimate of 7.0 USD and a high target estimate of 14.0 USD. The target price represents the price at which analysts believe the stock may trade in the future.

Capital Flow and Support/Resistance Levels:

Capital Flow: Over the past 5 days, the capital flow for Verastem has seen fluctuations. Notably, on 12-26, there was a large inflow of 1154.01K USD. However, on 12-27, there was a significant outflow of -821.06K USD. Monitoring the capital flow can provide insights into investor sentiment and market dynamics.

Support and Resistance Levels: As of 2024-12-30, the support price for Verastem is 2.96 USD, while the resistance price is 3.73 USD. These levels represent potential price ranges where the stock could find buying support or face selling pressure.